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Abstract: Two novel clusters of cephalosporin based on calixarene were synthesized directly or by ring expansion of the
penicillin arms of calixpenams to the corresponding cephem arms via sulfoxide intermediates. Antibiotic tests showed that
calixcephems have a noteworthy increase in antibacterial activity against methicillin-resistant strains of Staphylococcus
aureus (MRSA) with respect to parent calixpenams and their corresponding single cephems.
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1. Introduction
Antibiotic resistance is a serious and growing phenomenon in contemporary medicine and has emerged as one of
the pre-eminent public health concerns of the 21st century, particularly as it pertains to pathogenic organisms.
The resistance of infective bacteria to present antibiotics demands research assigned to the discovery of new
drugs in the antibacterial drug field.1,2
Staphylococcus aureus is an anaerobic gram-positive, nonspore forming spherical bacterium that belongs
to the genus Staphylococcus. Approximately 50% of humans are carriers of this organism and it is a common
cause of skin infections (e.g., boils), respiratory disease (e.g., sinusitis), and food poisoning. S. aureus was the
first bacterium resistant to penicillin. The staphylococcal β -lactamase protein, which cleaves the β -lactam
ring structure, confers resistance to penicillin. Disease-associated strains often promote infections by producing
potent protein toxins, and expressing cell-surface proteins that bind and inactivate antibodies. 3
The cephalosporins are a class of β -lactam antibiotics originally derived from the fungus Cephalosporium
acremonium in Sardinia in 1948 by Italian scientist Giuseppe Brotzu. 4 They constitute a subgroup of β -lactam
antibiotics called cephems. They have a core structure, consisting of a 2-ring system that includes a β -lactam
ring condensed with a dihydrothiazine ring (Figure 1). The cephalosporin nucleus, 7-aminocephalosporanic
acid (7-ACA), was derived by hydrolysis from the natural cephalosporin C and proved to be analogous to
the penicillin nucleus 6-aminopenicillanic acid (6-APA), but it was not sufficiently potent for clinical use. 5
Further work by Robert Morin led to semisynthesis of 7-amino-deacetoxycephalosporanic acid (7-ADCA) from
penicillins (the Morin ring expansion), which is convenient because penicillins can be fermented with more
ease than cephalosporins. 6 Chemical compounds containing this core are relatively stable to acid hydrolysis
and tolerant to β -lactamases. 4 In vitro stability can be enhanced by the addition of hydrogen to positions α1
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and α2 of the cephalosporin structure (Figure 1). The cephalosporins like other β -lactams have the ability
to kill bacteria by disrupting the transpeptidation step in the synthesis of the peptidoglycan layer of bacterial
cell walls, which in the end results in osmotic lysis and death of the bacterial cell. 7 Cephalosporins are widely
used antibiotics because of their clinical efficiency and desirable safety profile (due to their lower allergenic and
toxicity risks as well as a board spectrum of activity). 8

Figure 1. Chemical structure of cephalosporins.

First generation cephalosporins have good antimicrobial activity against gram-positive bacteria (Staphylococcus) but limited activity against gram-negative species (E. coli ). 9 The chemical structures of the first
generation cephalosporins are fairly simple. The common side groups at C-3 (R 2 ) for first class cephalosporins
are small uncharged groups like methyl (7-ADCA core). 10
Compared to penams, cephems are less susceptible to β -lactamase (more active against penicillinaseproducing bacteria such as S. aureus) and more stable to acid hydrolysis. 4 In addition, it is thought that
antibiotic resistance is unavoidable, but medicinal chemistry can slow it down through the development of new
antibiotics. There should be many strategies in order to develop new drugs, such as drug clustering. 11,12 These
reasons prompted us to synthesize novel generations of cephems by using a firm molecular platform for the
demonstration of the cephalosporin cluster. This idea could result in novel molecular structures with enhanced
effects and antibiotic activities in comparison to single cephalosporin units (cephems V and X) and penicillin
clusters (calixpenams).
According to the reasons cited for medical applications of calixarenes, these structures are suitable for
the design and development of new drugs. 11,12
In our previous work, 11 we reported the synthesis and biological evaluation of calixpenams against
nonpenicillinase producing strains of Streptococcus, but herein we wish to report the antibacterial activities and
synthesis of calixarene derivatives of cephalosporins (calixcephems) by 2 different methods: direct synthetic
pathway according to a previous published method 11 and indirect pathway by Morin ring expansion. The
direct synthetic strategy, like the synthesis of calixpenams, involves grafting of the 7-ADCA moieties via the
formation of an amide bond between the calixarene platform and the cephem arm, but the indirect method
involves converting calixpenams to calixcephems by ring expansion of the thiazolidine sulfoxide ring 11 to the
dihydrothiazine ring (Figure 1) and the formation of 7-ADCA cores (cyclic sulfoxide rearrangement) in the
presence of silyl protection of the carboxylate groups of 6-APA arms.

2. Results and discussion
The indirect synthetic pathway of calixcephems is depicted in Scheme 1. The target compounds were synthesized
from calixpenams during 2 steps consisting of conversion of calixpenams (1 and 2) to their sulfoxide derivatives
(3 and 4, respectively) followed by ring expansion to produce calixcephems (5 and 6).
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Scheme 1. Indirect synthetic pathway to calixcephems.

For this purpose, the 6-APA moieties of the calixpenams should be oxidized to sulfoxide derivatives
using peracetic acid in cold aqueous medium. The mechanism of the formation of a calixpenam sulfoxide
proceeds by a nucleophilic attack of the sulfur atom on the peracid and hydrogen bonding of the peracid
to the amido proton (Scheme 2). The main reaction is followed by the ring expansion process, employing
N,N′ -bis(trimethylsilyl)urea (BSU) and pyridine-hydrogen bromide (Py-HBr) to produce calixcephems (silyl
protection method). The mechanism of the ring expansion of the 6-APA sulfoxide moieties for producing the
7-ADCA cores (cyclic sulfoxide rearrangement) is depicted in Scheme 3. As shown, the mechanism involves
sulfenic acid and sulfonium ion.

Scheme 2. The mechanism of the formation of calixpenam sulfoxide by peracid.

The highest yield for the acid-catalyzed ring-expansion process was obtained with hydrogen bromide as
a catalyst in the presence of a small amount of pyridine as weak base (Py-HBr). 13
In the ring expansion reaction, it is necessary to protect the carboxyl groups due to decarboxylation
of nonprotected groups. The main advantages of silylation over other methods in the protection of carboxyl
groups are its easy introduction and removability. However, silyl esters are very sensitive to cleavage by water
and this is mainly caused by decarboxylation of nonprotected carboxylic groups. 13 In addition, the conversion
852
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of a calixpenam sulfoxide to a calixcephem implies the leaving of a molecule of water (Scheme 3); therefore,
trapping the water formed during the ring expansion is necessary to avoid deprotection of the silylated carboxyl
groups. On the other hand, using trimethylchlorosilane as silylating agent to protect the carboxyl group in the
TMS form causes a rise in the amount of HCl (Cl − of silyl compound) during the reaction and formation of
oxazolone thiazolidine (non- β -lactam) as the by-product of a side reaction (due to higher reactivity of HCl than
the silylated β -lactams toward reactive intermediates). 13 To solve these problems, BSU was used as a special
silylating agent with a strong silylating capacity and ability to trap the water formed during the ring expansion
and did not give rise to the formation of acids during the reaction. 13 To eliminate the silyl group, hydrolysis
using an aqueous solution of potassium bicarbonate was performed at elevated temperatures (50−60 ◦ C).

Scheme 3. The mechanism of ring expansion (cyclic sulfoxide rearrangement).

Like the previously published method, 11 in order to increase the solubility of the final products in
chloroform (recording of NMR spectra) and water (in-vitro antimicrobial susceptibility testing), their potassium
salt forms were prepared. The products’ structures were characterized by IR, NMR, and ESI-MS spectra and
elemental analysis.
The presence of the S=O double bond in the structure of sulfoxide derivatives can be easily verified by
a band at 1032 and 1035 cm −1 for compounds 3 and 4, respectively, in the FT-IR spectra.
IR analysis showed the presence of intense bands at about 1780, 1720, and 1680 cm −1 for CC X and
CC V attributed to the lactam carbonyl, carboxyl carbonyl, and amide carbonyl groups, respectively.
Like calixpenams 1 and 2, 11 compounds 5 and 6 (calixcehems) are in a cone conformation, as assessed
by the Ar–CH 2 –Ar resonance signals at 31.2 and 30.9 ppm in the 13 C NMR spectra, respectively. It was also
confirmed through the presence of an AB system at 4.47–3.38 ppm (JAB = 14 Hz) for 5 and at 4.34–3.42 ppm
for 6 in the 1 H NMR spectra.
It is known that compounds possessing cephalosporanic acid cores have greater antibacterial effects
against β -lactamase-producing bacterial strains in comparison to compounds with penicillanic acid cores; 4
thus, in order to evaluate this property of calixcephems (5 and 6), we compared them with the corresponding
calixpenams (1 and 2 respectively) against β -lactamase-producing strains of Staphylococcus aureus. On the
other hand, for showing the clustering effect of calixarene scaffold, we compared calixcephems with the corresponding single cephems 7 and 8 (Figure 2). Compounds 7 and 8 are single semisynthetic cephems (cephems V
and X, respectively) that are analogous to penams V and X. To obtain the best comparison, we chose 5 strains of
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the bacterium, consisting of 1 non- β -lactamase-producing strain (ATCC 25923) and 4 β -lactamase-producing
strains (2 methicillin-sensitive (MSSA) strains and 2 methicillin-resistant (MRSA) strains). In detail, 1 of
the 2 β -lactamase-producing methicillin-sensitive strains is penicillin-resistant (ATCC 11632), but the other is
penicillin-susceptible (ATCC 29213). The MRSA strains are ATCC 43300 and ATCC 33591.

Figure 2. Structural comparison between calixcephems and their corresponding single cephems.

The in vitro antimicrobial susceptibility testing (AST) (e.g., minimum inhibition concentration (MIC)
determination) of the cluster compounds was determined by broth microdilution (BMD) without 5% lysed sheep
blood, in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines, and as described
previously. 11 The results of these tests are shown in Table 1. As shown, cluster cephems CC X and CC V
showed great antibiotic activities in comparison to the corresponding calixpenams 1 and 2 (cephalosporin core
effect) and the corresponding single cephems V and X (calixarene clustering effect) against MRSA and penicillinresistant MSSA (ATCC 11632) strains of S. aureus (these strains were completely resistant to calixpenams).
As shown in Table 2, the MIC ratio of calixcephem and its corresponding monomer indicates the clustering
effect of calixarene scaffold. 11,12 In the case of MSSA strains (both β -lactamase-producing ATCC 29213 and
non- β -lactamase-producing ATCC 25923), the calixpenams showed more antibacterial effects with respect to
calixcephems (about 4- and 10-fold, respectively). S. aureus ATCC 33591 is a special strain, used for drug
discovery, and it is resistant to different kinds of common antibiotic such as oxacillin (MIC > 64 µ g/mL).
ATCC 43300 is also resistant to oxacillin (MIC = 16 µ g/mL). Both ATCC 33591 and ATCC 43300 are more
sensitive (about 10-fold) to calixcephems in comparison to cephalosporin monomers.

Table 1. Minimal inhibitory concentration (MIC) in µ g/mL for 5 strains of S. aureus.

MIC (µ g/mL) values
ATCC 25923
Strain
β − lactamase
(–)
Compd.
MSSA
6 (CC X)
0.225
5 (CC V)
0.250
2 (CP X)
0.025
1 (CP V)
0.032
7 (Ceph. V) 1.775
8 (Ceph. X) 1.550
854

ATCC 29213
β − lactamase
(+)
MSSA
0.992
1.012
0.240
0.256
5.325
5.150

ATCC 11632
β − lactamase
(+)
MSSA
0.912
0.925
> 64
> 64
8.775
8.350

ATCC 43300
β − lactamase
(+)
MSSA
1.150
1.225
> 64
> 64
11.775
10.950

ATCC 33591
β− lactamase
(+)
MSSA
1.550
1.635
> 64
> 64
16.650
16.325
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Table 2. MIC ratios between calixcephems and their corresponding monomers for 5 strains of S. aureus.

Strain
MIC ratio
MICCeph. V / MICCC V
MICCeph. X / MICCC X

ATCC
25923
7.1
6.9

ATCC
29213
5.3
5.2

ATCC
11632
9.5
9.1

ATCC
43300
9.6
9.5

ATCC
33591
10.2
10.5

In summary, the present work describes the first examples of calixcephems with efficient antibiotic
activities against MRSA strains and penicillin-resistant MSSA strain. These compounds could be considered
novel antibiotic structures with high density antibiotic surfaces.
The results of the present study demonstrate a noteworthy increase in antibacterial properties from
calixpenams (1 and 2) to their corresponding cephalosporin derivatives (5 and 6) against β -lactamase-producing
methicillin-resistant strains of Staphylococcus aureus (MRSA). This is attributed to the lower susceptibility of
cephalosporin cores to β -lactamase in comparison to 6-APA core.
Moreover, the results showed that calixcephems were more active (about 10-fold) against MRSA with
respect to the corresponding single cephems V and X. This is attributed to their high density antibiotic surface
and the synergistic effect of cluster arms (clustering effect).
3. Experimental
3.1. General
The melting points of all compounds were recorded on a Philip Harris C4954718 apparatus without calibration.
IR spectra were determined on a Thermo Nicolet 610 Nexus FT-IR spectrometer with KBr disks. Ultraviolet
spectra were recorded on a Shimadzu UV-2401/PC spectrometer.

1

H NMR (400 MHz) and

13

C NMR (100

MHz) measurements were recorded on a Bruker AM-400 spectrometer in CDCl 3 using TMS as the internal
reference. Elemental analyses were obtained on a PerkinElmer 240c analyzer. Mass spectra were recorded on a
JEOL-JMS 600 (FAB MS) instrument. Thin layer chromatography (TLC) analyses were carried out on silica gel
plates. All chemicals were purchased from Merck (Tehran, Iran) and used as received by standard procedures.
3.2. Sulfoxidation: procedure for the synthesis of compounds 3 and 4
Compound 1 or 2 (800 mg, 0.5 mmol) in the tetra potassium salt form 11 was dissolved in bidistilled water (5
mL) and then the solution was cooled to 0–5

◦

C, and 40% peracetic acid (5 mL, 0.9 mol) was added to the

solution followed by stirring for 3 h. Then a sufficient amount of 10% (w/w) sulfuric acid solution was added
dropwise until pH 2 was achieved. At constant pH and temperature, compound 3 or 4 crystals appeared. The
mixture was stirred at pH 2 for 2 h, filtered, and washed with distilled water (20 mL) to obtain the pure target
sulfoxide.
3.2.1. 25,26,27,28-Tetrakis(6-aminopenicillanic acid sulfoxide carbonylmethoxy)calix[4]arene (3)
Yield (640 mg, 85%), mp: 218–220

◦

C. IR (KBr, ν , cm −1 ): 3389 (O–H), 1792 (C=O), 1733 (C=O), 1676

(C=O), 1032 (S=O). The expanded structure of 6-APA sulfoxide is shown in Figure 3.

1

H NMR (400 MHz,

CDCl 3 , in the form of potassium salt) δ 8.22 (d, J = 9.8 Hz, 4H, N–H), 7.12 (d, J = 7.6 Hz, 8H, Ar-H m ),
6.68 (t, J = 7.6 Hz, 4H, Ar-H p ) , 5.91 (dd, J = 4.5 and 9.8 Hz, 4H, H-6 of APA), 4.95 (d, J = 4.5 Hz, 4H,
H-5 of APA), 4.61 (s, 4H, H-3 of APA), 4.56 (d, J = 14.0 Hz, 4H, ArCH 2 Ar H ax ), 3.92 (s, 8H, ArO–CH 2 ),
855
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3.45 (d, J = 14.0 Hz, 4H, ArCH 2 Ar H eq ), 1.67 (s, 12H, CH 3 ), 1.25 (s, 12H, CH 3 ). FAB
(M

+

+

MS m/z: 1512.39

).

3.2.2. 5,11,17,23-Tetrakis(6-aminopenicillanic acid sulfoxide carbonylmethyl)calix[4]arene-25,26,27,
28-tetrol (4)
Yield (665 mg, 88%), mp: 226–227

◦

C. IR (KBr, ν , cm −1 ): 3372 (O–H), 1789 (C=O), 1731 (C=O), 1670

(C=O), 1035 (S=O). The expanded structure of 6-APA sulfoxide is shown in Figure 3.

1

H NMR (400 MHz,

CDCl 3 , in the form of potassium salt) δ 9.68 (s, 4H, OH), 8.33 (d, J = 10.0 Hz, 4H, N–H), 7.06 (s, 8H, Ar-H),
5.99 (dd, J = 5.0 and 10.0 Hz, 4H, H-6 of APA), 5.05 (d, J = 5.0 Hz, 4H, H-5 of APA), 4.47 (s, 4H, H-3
of APA), 4.32 (bd, 4H, ArCH 2 Ar H ax ), 3.72 (s, 8H, CH 2 CO 2 ) , 3.38 (bd, 4H, ArCH 2 Ar H eq ), 1.72 (s, 12H,
CH 3 ), 1.23 (s, 12H, CH 3 ). FAB

+

MS m/z: 1512.30 (M

Figure 3. The numbering system for

1

+

).

H NMR spectrum of 6-APA sulfoxide.

3.2.3. Cyclic sulfoxide rearrangement: procedure for the synthesis of compounds 5 and 6
N,N′ -bis(trimethylsilyl)urea (500 mg, 2.4 mmol) was dissolved in toluene (20 mL), and then compound 3 or 4
(500 mg, 0.3 mmol) in the tetra potassium salt form was poured into the solution. The solution was stirred at
70 ◦ C for 1 h. After that, pyridine-HBr (100 mg, 0.62 mmol) was added, and the solution was refluxed in argon
atmosphere overnight. NaHCO 3 4.5% (w/v) solution (50 mL) was poured into the solution at 70 ◦ C, and the
pH of the solution was adjusted to 8. The solution was stirred for 2 h. After that, sulfuric acid 10% (w/w)
solution was added to the solution dropwise to initiate the crystallization at 50 ◦ C and the pH was adjusted
to 2. The solution was cooled to 0–5 ◦ C gently with stirring and then it was filtered. The solid product was
washed with distilled water (50 mL) to obtain the pure target compound 5 or 6.
25,26,27,28-Tetrakis(7-aminodeacotoxycephalosporanic acid carbonylmethoxy)calix[4]arene
(5)
Yield (400 mg, 93%), mp: 192–194

◦

C. IR (KBr, ν , cm −1 ) : 3396 (O–H), 1781 (C=O), 1722 (C=O),

1683 (C=O). The expanded structure of 7-ADCA is shown in Figure 4.

1

H NMR (400 MHz, CDCl 3 , in the

form of potassium salt) δ 8.52 (d, J = 9.5 Hz, 4H, N–H), 7.17 (d, J = 7.0 Hz, 8H, Ar-H m ), 6.72 (t, J = 7.0
Hz, 4H, Ar-H p ), 5.89 (dd, J = 4.8 and 9.5 Hz, 4H, H-7 of ADCA), 5.03 (d, J = 4.8 Hz, 4H, H-6 of ADCA),
4.57 (s, 8H, ArO–CH 2 ), 4.47 (d, J = 14.0 Hz, 4H, ArCH 2 Ar H ax ), 3.38 (d, J = 14.0 Hz, 4H, ArCH 2 Ar H eq ),
3.25 (AB, q, J = 18.4 Hz, 8H, H-2 of ADCA) 2.08 (s, 12H, CH 3 ) ;

13

C NMR (100 MHz, CDCl 3 , in the form

of potassium salt) δ 169.6 (CONH), 164.8 (C-8 of ADCA), 160.2 (COO), 156.8 (ArC–O), 137.6 (C (o) of Ar),
129.0 (C (m) of Ar), 125.7 (C-4 of ADCA), 122.9 (C (p) of Ar), 120.2 (C-3 of ADCA), 74.9 (ArO–CH 2 ), 66.7
(C-6 of ADCA), 58.2 (C-7 of ADCA), 45.2 (C-2 of ACDA), 31.2 (ArCH 2 Ar), 20.1 (C of Me). Anal. Calcd for
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C 68 H 64 N 8 O 20 S 4 : C, 56.66; H, 4.48; N, 7.77; S, 8.90. Found: C, 56.74; H, 4.43; N, 7.83; S, 8.87. FAB
m/z: 1440.36 (M

+

+

MS

).

3.2.4. 5,11,17,23-Tetrakis(7-aminodeacotoxycephalosporanic acid carbonylmethyl)calix[4]arene-25,
26,27,28-tetrol (6)
Yield (415 mg, 96%), mp: 186–188

◦

C. IR (KBr, ν , cm −1 ): 3380 (O–H), 1778 (C=O), 1720 (C=O), 1681

(C=O). The expanded structure of 7-ADCA is shown in Figure 4.

1

H NMR (400 MHz, CDCl 3 , in the form

of potassium salt) δ 9.70 (s, 4H, OH), 8.73 (d, J = 9.8 Hz, 4H, N–H), 6.97 (s, 8H, Ar-H), 6.01 (dd, J = 5.0
and 9.8 Hz, 4H, H-7 of ADCA), 4.95 (d, J = 5.0 Hz, 4H, H-6 of ADCA), 4.45 (s, 8H, CH 2 CO 2 ), 4.34 (bd, 4H,
ArCH 2 Ar H ax ), 3.42 (bd, 4H, ArCH 2 Ar H eq ), 3.30 (AB, q, J = 19.0 Hz, 8H, H-2 of ADCA), 2.13 (s, 12H,
CH 3 );

13

C NMR (100 MHz, CDCl 3 , in the form of potassium salt) δ 170.4 (CONH), 165.2 (C-8 of ADCA),

163.1 (COO), 149.8 (ArC–O), 128.2 (C (o) of Ar), 127.6 (C (m) of Ar), 127.1 (ArC*–CH2), 124.8 (C-4 of ADCA),
119.9 (C-3 of ADCA), 65.9 (C-6 of ADCA), 58.7 (C-7 of ADCA), 45.9 (C-2 of ADCA), 39.0 (*CH 2 CO), 30.9
(ArCH 2 Ar), 19.8 (C of Me). Anal. Calcd for C 68 H 64 N 8 O 20 S 4 : C, 56.66; H, 4.48; N, 7.77; S, 8.90. Found: C,
56.63; H, 4.52; N, 7.80; S, 8.79. FAB

+

MS m/z: 1440.35 (M

Figure 4. The numbering system for

1

+

).

H NMR spectra of 7-ADCA.

3.3. Bacterial strains
In the present study, microbiological tests were carried out with cluster compounds against 5 gram-positive
standard strains of Staphylococcus aureus, consisting of 2 β -lactamase-producing methicillin-resistant (MRSA)
strains ATCC 43300 and ATCC 33591 and 3 methicillin-sensitive (MSSA) strains, including 1 non-β -lactamaseproducing strain ATCC 25923 and 2 β -lactamase-producing strains ATCC 29213 and ATCC 11632, the latter
of which is a penicillin-resistant strain.
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